The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 28, 2018
Filed:
Jan. 24, 2017
Applicant:
Biogen MA Inc., Cambridge, MA (US);
Inventors:
Vincent P. Sandanayaka, Northboro, MA (US);
Sharon Shechter, Andover, MA (US);
Sharon Shacham, Newton, MA (US);
Dilara McCauley, Arlington, MA (US);
Erkan Baloglu, Stoneham, MA (US);
Assignee:
Biogen MA Inc., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/497 (2006.01); A61K 31/454 (2006.01); A61K 31/4196 (2006.01); C07D 401/10 (2006.01); C07D 249/08 (2006.01); C07D 413/12 (2006.01); C07D 403/12 (2006.01); C07D 401/12 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4196 (2013.01); A61K 31/454 (2013.01); A61K 31/497 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 249/08 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 413/12 (2013.01);
Abstract
The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I, and methods of using the compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.